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Abstract 
 The detection of enantiomeric purity is an important part of synthetic chemistry. 
Especially when developing medicinal compounds the determination of the amount of 
enantiomeric impurities is important as one of the enantiomers may be poisonous or lethal 
to humans. Various methods exist for the study of enantiomeric purity and NMR 
spectroscopy has been intensively studied as a tool for this purpose. As NMR is fast, 
readily available and easy to use it provides an attractive way to study enantomeric purity.  
In NMR chiral discrimination is obtained by using chiral derivatising agents (CDAs) or 
chiral solvating agents (CSAs). CSAs have more potential in enantiomeric excess (ee) 
studies than CDAs as they lack of the disadvantaged of CDAs (e.g. kinetic resolution and 
racemisation). As chiral carboxylic acids are important in the synthesis of medicinally 
attractive compounds, natural products and their metabolites, CSAs which can be used for 
the determination of enantiomeric purity of carboxylic acids and are easily available and 
cheap are helpful.   
 
The present study mainly focuses on the development of CSAs suitable for the 
discrimination of non-ionic and ionic chiral carboxylic acids. (+)-Dehydroabietylamine 
was used as chiral building block for these new CSAs as it has several beneficial features 
such as easy availability, low price, an amenable structure for CSA construction and it is 
known to resolve chiral carboxylic acids via cystallisation. Three different series of non-
ionic and ionic CSAs were developed from (+)-dehydroabietylamine: 1) ammonium, 2) 
secondary amine and 3) imidazolium based CSAs. Their enantiomeric discrimination 
abilities were examined with Mosher’s acid and its tetrabutylammonium salt. Best 
resolution was obtained with non-ionic substrate and non-ionic CSA and with ionic 
substrate and ionic CSA. Ionic CSAs were also able to resolve non-ionic substrates but the 
enantiomeric resolution remained poor. 
 
The best performing CSAs were subjected for more detailed investigation. The 
stoichiometry of formed diastereomeric complex between the CSA and substrate was 
studied by titration experiment. CSA-substrate complexes were generally formed in 1:1 
ratio.  CSA applicability to function in ee determination was studied and they were able to 
detect the enantiomeric purities of samples with excellent reliability.  Finally their ability 
to resolve various α-substituted carboxylic acids was studied showing that (+)-
dehydroabietylamine based CSAs are suitable for chiral carboxylic acids containing 
electronegative α-substituent. 
 
Also the effect of measurement conditions and sample preparation when using cationic 
CSAs in enantiomeric discrimination was investigated. Lower temperatures and low 
polarity solvents were noticed to increase enantiomeric discrimination, among high CSA 
concentration. Delocalisation of negative charge in counter anion of CSA as well as the 
use of organic counter cation for the substrate was also notised to increase enantiomeric 
discrimination. 
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Abbreviations 
BINAPHAT  Bis(tetrachlorobenzenediolato)mono([1,1’]binaphthalenyl-2,2’-
diolato)phosphate 
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Boc   tert-Butyloxycarbonyl protecting group 
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n-Bu4P+  Tetrabutylphosphonium cation 
c  Concentration 
CD  Cyclodextrin 
CDA  Chiral derivatising agent 
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F  Electrostatic force of interaction between two point charges 
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HNTf2  Bis(trifluoromethane)sulfonimide 
HPLC  High performance liquid chromatography 
HSQC  Heteronuclear Single Quantum Coherence 
Me   Methyl 
Me4N+  Tetramethylammonium cation 
MTPA  α-Methoxy-α-trifluoromethylphenylacetic acid, Mosher’s acid 
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NMR  Nuclear magnetic resonance 
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NTf2-  Bis(trifluoromethylsulfonyl)imide  
Ph  Phenyl 
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TFA-  Trifluoroacetic carboxylate ion 
TfO-  Trifluoromethanesulfonate anion 
TRISPHAT  Tris(tetrachlorobenzenediolato)phosphate 
TOCSY  TOtal Correlation SpectroscopY 
 
 
 
 
11 
1 Introduction 
The knowledge of enantiomeric purity and recognition of the absolute configuration of 
a chiral compound is an important part of synthetic chemistry. Especially in 
pharmaceutical chemistry it is necessary to be able to determine the enantiomeric purity of 
a synthetised product, as some isomers of medicinal compounds may be poisonous or 
lethal to humans.1,2 Also the growing interest towards nature’s resources has increased the 
need for chiral analysis as many natural compounds and/or their metabolites are chiral.3 
Several methods exist for the analysis of chiral compounds. The most frequently applied 
method is HPLC (high performance liquid chromatography). Other commonly used 
methods include GC (gas chromatography), CE (capillary electrophoresis), chiroptical 
methods and NMR (nuclear magnetic resonance) spectroscopy.2,4-8 
 
HPLC is the most commonly used and standardised chiral separation method in many 
laboratories. However, it has its limitations as chiral columns are often expensive, method 
development can be time consuming and long run-times may be required for proper peak 
separation.9 CE is frequently used in the analysis of biological samples (especially amino 
acids). The advantage of CE compared to other methods is the low sample concentration 
and the fast analysis. The major drawback of this method is that samples need to be in an 
ionic form.5 GC is less common in chiral analysis than CE or HPLC. In GC the 
investigation of thermally unstable compounds causes problems and in some cases the 
compounds have to be derivatised before analysis (e.g. phenolic compounds).10 Various 
chiroptical methods such as optical rotation and electronic circular dichroism are also used 
in the determination of enantiomeric purity.2  As with chromatographic methods also these 
have their drawbacks. For instance optical rotation, although it is fast, easy and cheap 
method it is highly dependent on temperature, concentration, solvent and possible 
impurities in the sample.9   
 
NMR spectroscopy is generally used to determine the structure of a synthesised 
compound, but it is more versatile tool that, however, can be used in reaction 
monitoring,11 the purity determination of a sample12 and studying reaction and structural 
dynamics13. NMR is also an excellent tool for studying the properties of chiral selectors 
and chiral solid phases for e.g. HPLC.14-17 NMR is also one of the few tools, that can be 
used for determining the absolute configuration.6,18 In this field NMR spectroscopy has 
one advantage over the commonly used X-ray crystallography since it can be used for the 
determination of absolute configuration of liquid samples.15 NMR spectroscopy has also 
been used for chiral resolution.6,18,19 The applicability of NMR in purpose to study the 
enantiomeric purity or absolute configuration has usually been poor since a relatively high 
concentration of a sample has been required due to sensitivity issues. However, 
developments in sensitivity (stronger magnets, cryotechniques, nanoprobes etc.) has made 
NMR spectroscopy a more potential competitor for the other analytical methods.7 As the 
sensitivity of NMR has increased less sample is needed and accurate enantiomeric excess 
(ee) determinations can be performed up to 95% ee or somewhat higher.9,20-22 Although 
NMR spectroscopy is not as sensitive as HPLC, it provides an ideal tool for quick ee 
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measurements. The ease of use, simple sample preparation and ready accessibility makes 
NMR spectroscopy an attractive tool for ee determination both in asymmetric synthesis 
and in the development of new chiral catalysts. Also if enantiomeric resolution cannot be 
efficiently obtained with traditional methods NMR spectroscopy can be used as an 
option.23 Also the possibility to analyse biological samples without pre-treatment is one of 
the major advantages of NMR.24 
 
The use and development of chiral compounds for NMR to determine enantiomeric 
purity started in 1965 when Morton Raban and Kurt Mislow published their preliminary 
work showing that two diasteromers could be resolved in NMR.25,26  The next year 
William H. Pirkle demonstrated that not only diastereomers but also diastereomeric 
complexes can be resolved in NMR.27 Since then, new compounds and techniques have 
been developed for NMR for the determination of enantiomeric purity and absolute 
configuration. A data search made with SciFinder (using the search terms chiral solvating 
agents in NMR and chiral derivatising agents in NMR) indicated that the use of NMR in 
the study of chiral compounds is still a popular research topic in chemistry (Chart 1). 
 
 
 
 
Chart 1. Journal articles and patents published of the use and development of chiral NMR 
methods from 1990 to 2015. 
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1.2 Chiral resolution in NMR spectroscopy 
Chiral nuclei of enantiomers cannot be identified as such since their chemical 
environment is identical. To differentiate the enantiomers they require a diastereoisomeric 
environment.19 In NMR spectroscopy diastereomeric environment can be provided by 
using chiral derivatising agents (CDAs) or chiral solvating agents (CSAs). In the case of 
CSAs also achiral compounds, so called pro-CSAs, can be used though this is rare.28 The 
difference between CDAs and CSAs is that CDAs form a covalently bonded diastereomer 
with the enantiomers of a chiral substrate whereas CSAs form a non-covalently bonded 
diastereomeric complex.18,19 The success of chiral resolution in NMR spectroscopy is 
indicated by the magnitude of non-equivalence (Δδ= |δR–δS|, the absolute value of the 
chemical shift difference of the two enantiomers in the chiral environment). It indicates 
the strength of the diastereomeric interactions between a CDA or a CSA and the chiral 
substrate.18,19 
 
Both the use of CDAs and CSAs have their advantages and disadvantages (Table 1). 
CDAs are applicable both in absolute configuration determination and the measurement of 
enantiomeric excess (ee). CDAs are required to be 100% enantiomerically pure and 
compared to CSAs the use of CDAs is more time consuming due to derivatisation.6 The 
derivatisation reaction also causes concerns of kinetic resolution and racemisation.6,18,29,30 
The use of CDAs generally requires a high amount of sample for the derivatisation 
reaction. However, recently the development of polymer supported CDAs and single 
derivatisation have been able to reduce the consumption of the substrate.31 CSAs are more 
suitable for ee determination than for the determination of absolute configuration, 
although, some CSAs can also be used in this purpose.6,18 The advantage of CSAs 
compared to CDAs, in ee determination, is that high amounts of CSA nor chiral substrate 
are not needed. Also the complexation can be performed in the NMR tube making the 
CSAs user-friendlier. For CSAs 100% enantiomeric purity is not necessary (compared to 
CDAs).6,18,19,29 The enantiomeric purity of the CSA has an influence only on the Δδ, i.e., 
the higher the enantiomeric purity of the CSA, the larger the observed Δδ.19 In general 
only enantiomerically pure reagents are used as the Δδ generated by CSAs is usually 
smaller than that using CDAs.6,29 To enhance Δδ, lower temperatures, higher 
concentrations of CSA and the use of solvents with a low polarity have been noticed to be 
beneficial.18,19 Many specialised NMR techniques have been applied e.g. J-resolved32 and 
pure shift techniques33,34. Also the addition of DMAP (4-dimethylaminopyridine)35-39 to 
the mixture of CSA and the substrate has been noticed to increase the Δδ by tens of Hz.37 
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Table 1. Comparison between CSAs and CDAs. 
 CSA CDA 
Information obtained   
Enantiomeric purity  Yes Yes 
Absolute configuration Rare Yes 
   
Advantages and disadvantages   
100% enantiomeric purity Not necessary Necessary 
Racemisation No May happen 
Kinetic resolution No May happen 
Time consuming? No Yes 
Sample amount 
No need for a high amount of 
substrate 
High amounts of substrate 
needed (for derivatisation) 
Δδ generated  Commonly lower than CDA High 
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2. Chiral solvating agents and chiral derivatising agents 
in NMR spectroscopy 
Various compounds and compound groups have been developed and applied as CDAs 
and CSAs for the analysis of stereochemistry by NMR spectroscopy. Some of the CDAs 
and CSAs are versatile and suitable for several different types of compounds (e.g. amines, 
alcohols, carboxylic acids etc.). However, some are very specific and only certain types of 
compounds can be analysed (e.g. only acids). Their sizes range from small (e.g. mandelic 
acid) to macrocyclic compounds (e.g. cyclodextrins). The structures of CDAs and CSAs 
can be very similar and many of the CDAs can be used as CSAs. However, this does not 
always apply in the opposite direction as CSAs do not necessary contain groups for 
covalent bond formation which are necessary for CDAs. Both CDAs and CSAs commonly 
contain an aromatic unit as well as polar functional groups.18,19,29,40 This is due to the 
excellent shielding ability of aromatic rings and the hydrogen bonding abilities provided 
by polar groups.19,40 As mentioned before CDAs can be applied in both determination of 
absolute configuration and enantiomeric purity, whereas CSAs (in general) can only be 
used in the determination of enantiomeric purity. As the topic of this study was the 
development of new CSAs, the use of CDAs in NMR spectroscopy are only briefly 
commented whereas CSAs are more thoroughly discussed and various non-ionic and ionic 
CSAs are introduced. Also the mechanism of the enantiomeric purity determination is 
explored.  
2.1 CDAs 
Various CDAs have been developed such as carboxylic acids, amines, alcohols, and 
boron and phosphorus containing compounds.15,30,40,41 CDAs in general contain a polar or 
bulky group able to fix a particular conformation (e.g. methoxy, amine, aryl), a group able 
for covalent bonding (e.g. hydroxyl, amine, acid) and a group able to cause shielding (e.g. 
aromatic, carbonyl).15 In this section various CDAs used in the determination of absolute 
configuration are introduced and their use in this purpose is briefly commented. 
2.1.1 The assignment of absolute configuration 
The well-known method for the determination of absolute configuration with CDAs is 
based on the formation of diastereomers between a pure enantiomer and both of the 
enantiomers (R and S) of CDA.15,42 The success depends on the tendency of diastereomers 
to adopt preferable conformation and on a predictable and differential shielding caused by 
a suitable functional group in the CDA (e.g. an aromatic ring).40 As an example, when 
Mosher’s acid (α-methoxy-α-trifluoromethylphenylacetic acid, MTPA, 1) is used as CDA 
with secondary alcohols, the ester formed is presumed to adopt the syn-periplanar 
conformation (Fig. 1). The phenyl ring of MTPA causes the shielding of R1 with (R)-
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MTPA and R2 with (S)-MTPA.15,29,40 The group influenced by shielding moves to higher 
field (i.e. towards lower ppm values) in the NMR spectra and the absolute configuration 
can be predicted from the signs of the ΔδRS values.15 It is important to notice that the 
successful assignment of the absolute stereochemistry requires that the compound exhibits 
the same trend in chemical shifts. To increase the accuracy of the configurational 
assignment it is important to study model compounds with similar structural features.40 
 
  
Figure 1. Example of the conformational model of R- and S-Mosher’s acid (1) with a secondary 
alcohol.15,29,40 
2.1.2 Different types of CDAs 
 
MTPA is probably the most well known CDA. Since 1973 when Harry S. Mosher and 
James A. Dale published their paper for its use in the determination of absolute 
configuration of secondary alcohols,43 it has been applied for the determination of absolute 
configuration of various compounds.43-49 The so called Mosher method for absolute 
configuration determination is one of the most well known in this field. Even though 
better CDAs have been developed MTPA continues to be the most frequently used 
CDA.40   
 
The majority of the acid based CDAs are aryl-containing carboxylic acids such as α-
methoxyphenylacetic acid (2),43,44,50,51 mandelic acid (3),43,52,53  2-methoxy-2-(1-naphthyl) 
propionic acid (4),54-56 and α-(9-anthryl)-α-methoxyacetic acid (5)42,57,58. However, non-
aromatic carboxylic acid based CDAs (e.g. menthoxyacetic acid, 659) have also been 
studied but their use has been limited.30 Acid based CDAs are commonly used for racemic 
alcohols, amines and diols.15,30,40 
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Figure 2. Carboxylic acid based CDAs. 
 
Alcohol based CDAs are less common than carboxylic acid ones, nevertheless, several 
alcohol based CDAs have been developed such as 1-phenylethanol (7),60 methyl 
mandelate (8),61 octahydro-8,9,9-trimethyl-5,8-methano-2H-1-benzofuran-2-ol (9)62-64 and 
menthol (10)65-67. Glycosides such as D-glucose (11)68,69 and D-mannose68 have also been 
applied as CDAs. Certain diols (e.g. butane-2,3-diol, 12) have been noticed to be good 
CSAs for some chiral ketones.70 Alcohols have been commonly applied in the 
determination of the absolute configuration of carboxylic acids60,61,64-67 and 
alcohols,62,63,68,69 also other compounds have been studied such as amides,64 esters64 and 
thiols62. 
 
 
Figure 3. Alcohol based CDAs.  
 
The third largest group of CDAs consists of amines.30 Certain primary and secondary 
amine compounds can be used for the identification of stereochemistry. For instance, 1-
phenylethylamine (13),71-73 1-(1-naphthyl)ethylamine (14),72,73 and ephedrine (17)74,75 
have been used. Also amino acid derivatives such as phenylglycine methyl ester (16)76-78 
and phenylglycinol (17)79 have been used. For instance phenylglycine methyl ester has 
been often used to define absolute configuration of biological compounds.76,78 Amines are 
commonly used in the absolute configuration determinations of carboxylic acids,72,73,77 
however, also the absolute configuration of aldehydes,75,79 metal complex71 and 
phosphorus compounds74 have been identified. 
 
 
Figure 4. Amine based CDAs. 
 
H3CO
OH
OCH3
O
OH
O
OH OH
O
OH
O
H3CO
H3C
O
OH
O
2 3 4 65
OHH3C
O
O
OH
O
OH
H
H
HO
O
H
HO
H
HO
H
H
HOH OH
OH
OH
OH
7 8 9 10 11 12
NH2H3C H3C NH2 NH2O
O
HO
HN
NH2HO
13 14 16 1715
 
 
 
 
18 
Ketone, aldehyde and isocyanate based CDAs have also been applied in absolute 
configuration determination of various compounds in NMR spectroscopy.40 Aldehyde and 
ketone based CDAs have been noticed to be useful when studying the stereochemistry of 
diols. For example 2’-methoxy-1,1’-binaphthalene-8-carbaldehyde (18),80 and 1-menthone 
(19)81 have been used for 1,2- and 1,3-diols. Isocyanate compounds (e.g. α-methoxy-α-
(trifluoromethyl)benzyl isocyanate, 20)82 have been also applied and they are sometimes 
preferred over acid chlorides when studying the chirality of amines and alcohols as their 
application can avoid the use of dehydrochlorinating agent and the removal of the formed 
hydrochloride while preparing the studied derivative.82 
 
A few phosphorus, boron and silicon containing CDAs have been developed. For 
instance, 2-chloro-3-phenyl-1,3,2,-diazaphosphabicyclo[3.3.0]octane-2-oxide (21) was 
used for the determination of stereochemistry of amines and alcohols.83 The boron 
compound 2-(1-methoxyethyl)phenylboronic acid (22) was applied in the determination of 
stereochemistry of cis-diols.84 Even though silyl compounds are considered to enable an 
easier derivatisation and recovery of the original chiral compound compared to e.g. 
carboxylic acids (e.g. MTPA), they are less common. For instance, [(S)-1-
[(chlorodimethylsilyl)oxy]-2,2,2-trifluoroethyl]-benzene (23) was applied in the 
determination of absolute configuration of secondary alcohols.85 
 
 
Figure 5.  Miscellaneous CDAs.  
2.2 CSAs 
Chiral amines, alcohols, acids, cavity compounds, metal complexes, liquids crystals 
and various other compounds have been employed as CSAs.19 CSAs may be ionic or non-
ionic, however, most of the developed CSAs are non-ionic. The key step in chiral 
resolution with CSAs is the formation of diastereomeric complexes between enantiomers 
and the CSA.19 To ensure this behaviour the CSA must be a pure enantiomer and should 
provide interactions such as hydrogen bonding, π-π stacking or ionic and dipolic 
interactions.6,7,18 In this section various CSAs are introduced and their mechanism in the 
enantiomeric purity determination is briefly discussed. As in our research we have been 
interested in developing cationic and non-ionic amine and imidazole based CSAs the 
amine based CSAs and cationic CSAs are treated here in more detail than others. Chiral 
metal compounds such as lanthanide complexes are often considered as their own class 
(not as CDA or CSA) and defined as chiral shift reagents. Here they are classified as 
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CSAs because they are generally not covalently bonded to the substrate. The same applies 
to liquid crystals and in here they are also classified as CSAs.  
2.2.1 The assignment of enantiomeric purity 
Chiral recognition with CSAs can be performed in two ways. One is that the CSA-
substrate complexes are diastereomers (e.g. diastereomeric salts) that have different 
chemical shifts. The signal splitting originates from the different coordination of R and S 
forms of the chiral substrate with the enantiomerically pure CSA molecule (i.e. different 
geometry of formed complex). The other is that the two enantiomers of the chiral substrate 
have different association constants with the CSA, such that the time averaged solvation 
environments are different.6,18,19 In other words the diastereomeric complex is in 
equilibrium with its unbound species. As in the NMR timescale this equilibrium is often 
under fast exchange, the observed chemical shifts of enantiomers are the weight average 
of the corresponding chemical shifts of the free and complexed species.6,22 In many cases, 
both mechanisms are likely to contribute to some extent to the non-equivalence of the 
enantiomers (Fig. 6).6,18,19,29   
 
 
Figure 6. Illustration of hypothetical complex formation and its effect to the chemical shift. 
2.2.2 Non-ionic CSAs   
2.2.2.1 Small to medium sized CSAs 
One of the first CSAs ever used was 2,2,2-trifluorophenylethanol (24).86-90 It can be used  
as CSA for the determination of enantiomeric purity but also to determine absolute 
configuration.86,88,89 The discovery of 24 led to the development of new alcohol based 
CSAs. One of these was Pirkle’s alcohol, 2,2,2-trifluoro-1-(9-anthryl)ethanol (25),91-98 
which is considered as the most popular and versatile CSA ever developed.6,19 It has been 
used for the determination of enantiomeric purity of various compounds such as 
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lactones,96 amines91  and sulfoxides94, and it has also been applied to prove the chiraliry of 
metal complexes98.  As a CSA Pirkle’s alcohol is highly useful as it can also be used for 
the determination of absolute configuration and it has been used successfully for 
lactams,97 lactones92,95,96 and sulfoxides93. After the invention of Pirkle’s alcohol, many 
structurally related CSAs have been developed such as α,α’-bis(trifluoromethyl)-1,8-
anthracenedimethanol (26)99 and α,α’-bis(trifluoromethyl)-9,10-anthracenedimethanol 
(27)100. One interesting alcohol based CSA is the axial chiral (atropisomeric) compound 
1,1’-bi-2-naphthol (BINOL) (28). It has been used for the enantiomeric discrimination of 
various compounds such as amines,101 alkaloids,102 several medicinally important 
compounds,9,103,104 phosphine oxides101 and sulfoxides101. Alcohol based CSAs are 
versatile and they have been applied in ee determination of various compound classes such 
as sufoxides,87,88,93,94,101 amines9,91,99-102,104, alcohols,99-101 and lactones92,95,96. 
 
 
Figure 7. Alcohol based CSAs. 
 
Chiral carboxylic acids have been more commonly used as CDAs than as CSAs. This 
is interesting as carboxylic acids are cheap, widely available and would be excellent CSAs 
for amines due to their ability to form diastereomeric salt. Carboxylic acid based CSAs are 
usually aromatic. However, some non aromatic carboxylic acid CSAs have been used [e.g. 
(S)-(+)-lactic acid ((S)-29)105].19 Mandelic acid (3)105-107 and several of its derivatives 
(such as O-methyl mandelic acid (30),108,109 O-nitro mandelic acid,110 and O-aryl and O-
heteroaryl mandelic acids111) have been used in the enantiomeric separation of 
amines,110,111  alcohols,110  sulfoxides108 and various other classes of compounds110,111. 
MTPA (1) has also been applied as a CSA although it is better known for its use as 
CDA.105,112-115 Some carboxylic acids used as inflammatory drugs have also been studied. 
For instance (S)-naproxen (31) was used for the enantiomeric separation of atropisomeric 
phosphine oxides41 and chiral sulfoxides116. (S)-Ibuprofen has also been applied as a CSA 
for chiral sulfoxides.116 The most common compound classes examined by carboxylic acid 
CSAs are amines106,107,109-111,113,114,117 and other nitrogen containing compounds.105,112,118 
However, also various other compounds such as sulfoxides,108,116 alcohols110 and 
oxetanes119 have been studied. 
 
 
Figure 8. Carboxylic acid based CSAs. 
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Even though acids, amines and alcohols are the most popular small to medium sized 
CSAs also other compounds have been studied. For instance amides and lactams have 
been considered attractive CSAs due to their ability to interact with the substrate trough 
dipole-dipole interactions and co-operative hydrogen bond donor and acceptor 
interactions.19 For instance, N-(3,5-dinitrobenzoyl)-1-phenylethylamine (32) has been used 
for the determination of the optical purity of phospholene oxides.120 The lactam 1,5,7-
trimethyl-3-azabicyclo[3.3.1]nonan-2-one (33) can be successfully used for enantiomeric 
discrimination of lactams, quinolones and oxazolidinones.22 Imidazole and thiourea based 
CSAs are less common but compounds such as the bisimidazoline based CSA 34121 and 
N,N’-bis[(S)-1-(α-naphthyl)ethyl]thiourea (35)122 has been used for the ee determination 
of carboxylic acids. Compounds containing a heteroatom such as phosphorus, selenium or 
boron are more often used as CDAs but some CSAs also exist such as the BINOL type 
1,1’-binaphthyl-2,2’-diyl hydrogenphosphate (36)123.30   
 
 
Figure 9. Amide, lactam, bisimidazoline, thiourea and phosphorus CSAs.  
2.2.2.2 Transition metal and lanthanide complexes, cavity compounds and liquid 
crystals 
Several transition metal containing CSAs have been developed. For instance, rhodium 
[e.g. Rh2(MTPA)4, a rhodium dimer of Mosher’s acid, (37)124], platinum and palladium 
based metal complexes have been widely developed and investigated. Also other transition 
metals have been utilized, such as silver and ruthenium.30,125 A well-known class of metal 
containing CSAs are paramagnetic lanthanide shift reagents (e.g. europium complex 
38126). They have been proved to be very efficient for the enantiomeric resolution. 
However, they have some disadvantages. For instance, they cause peak broadening that is 
increased at the higher field strengths.30,125 Lanthanide reagents can also be used in 
collaboration with other CSAs such as cyclodextrins and crown ethers.125 
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Various cavity compounds have been used as CSAs in NMR. The most well known 
are cyclodextrins (CDs). Most common types are α-, β- and γ-CDs (39) with six, seven 
and eight glucose units, respectively. The native CDs can be used for several compounds 
(usually containing a phenyl ring). They also enable the analysis of chiral compounds in 
an aqueous medium that is suitable for the analysis of compounds poorly soluble in 
common organic NMR solvents. CDs can be easily modified as either the primary or 
secondary hydroxyl groups can be derivatised. The modification of CDs can be made to 
influence the solubility of CD to solvents, to enhance the enantiomeric discrimination and 
to tailor its affinity to the chiral compound studied.19,30 Other well-studied class of cavity 
compounds are crown ethers. They have been mainly used for the analysis of amines, 
generally primary but also secondary and tertiary amines have been studied.30 The amine 
under investigation can be either non-ionic or ionic.30 For instance, one of the most 
studied crown ethers, (18-crown-6)-2,3,11,12-tetracarboxylic acid (40), has been 
successfully used in the enantiomeric discrimination of different secondary, tertiary and 
prochiral amines.127 Also other cavity compounds such as calixarenes  (e.g 
calix[4](aza)crown 41128), calixresorcarenes and cyclic amides have drawn attention.19,30 
 
Chiral liquid crystals (CLCs) are an interesting type of chiral discriminating agents. When 
dissolved in an achiral co-solvent CLCs can partially align in the magnetic field and 
enantiomers dissolved in this mixture do the same. The enantiomers have a different 
orientation relative to the applied magnetic field leading to enantiomeric discrimination. 
No direct interactions are needed between the substrate and CLC.30,129 Interestingly, the 
distance from the stereogenic centre often has no influence and even nuclei remote from 
the stereogenic centre of the studied substrate often exhibit a large enantiomeric 
discrimination. A few CLCs have been applied as CSAs in NMR, poly-(γ-benzyl-L-
glutamate) (42)129 being the most commonly studied.30 
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Figure 10. Examples of lanthanide shift reagent, metal complex, cyclodextrins, crown ether, 
calixarene, and liquid crystal CSAs. 
2.2.2.3 Amine based CSAs 
Amines are one of the biggest classes of CSAs. A wide variety of primary, secondary 
and tertiary amine CSAs has been investigated. Among these, also the suitability of 
diamines and amino alcohols in enantiomeric discrimination has been studied.19 Like other 
CSAs (e.g. alcohols and acids) also amine CSAs are commonly aromatic. The first CSA 
ever reported was 1-phenylethylamine (13)27,130 developed by William H. Pirkle in 1966. 
It can even be used in the determination of absolute configuration of chiral phosphorus 
thio acids130 and alkylcarbinols131. Very soon after the discovery of 13 several structurally 
related aromatic amines were developed such as 1-(1-naphthyl)ethylamine (14)130-132 and 
1-(9-anthryl)ethylamine (43)133.  Several derivatives of these compounds have been made 
such as (S,S)-1-[phenyl(1-phenylethylamino)methyl]naphthalen-2-ol (45)134  a derivative 
of 13 and N-Boc-1-(1-naphthyl)ethylamine (46)135 a derivative of 14.134-137 
 
Various shaped amine CSAs have been developed. Some contain other functional 
groups such as hydroxyl groups as in BINOL based compound 47138. Also amines with 
amide functionality have been developed such as (1R,2S)-1-(1’,8’-naphthalimide)-2-
aminocyclohexane based primary amine 44.139 Primary amine based CSAs are more 
common than secondary or tertiary ones. Primary and secondary amines have one 
advantage over the tertiary ones as they have hydrogen acceptor and donor groups (NH2 or 
NH) whereas tertiary amines have only hydrogen acceptor group (N) as in the roof shaped 
amine 48140. This, however, is not an issue if molecule contains other functional groups 
able to hydrogen bonding as in 1’,8’-naphthalimide based CSAs 49141 and in the Tröger’s 
base derivative 50142.   
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Figure 11. Primary, secondary and tertiary amines used as CSAs. 
 
Naturally occurring chiral compounds such as ephedrine (15),143,144 quinidine (51),143 
quinine (52)143,145 strychnine (53)146 and brucine (54),147 have also been applied as CSAs. 
For instance, quinidine and quinine based CSAs have been used in the enantiomeric 
separation of N-protected aminoalkanephosphonates143 and carbamoyl derivatives145. 
  
 
Figure 12. Natural compounds used as CSAs. 
 
Also the ability of diamines to differentiate enantiomers have been studied.19,148,149 For 
instance, (R,R)-N,N’-bis(5-methylsalicyl)-1,2-diphenylethylenediamine (55) was used in 
the enantiomeric separation of carboxylic acids.148 Larger diamines and their derivatives 
such as 56150,151 can be called molecular tweezers. The ability of diamines and their 
derivatives to bind to carboxylic acids and resolve their enantiomers has been studied.19 
As diamines have two amine groups able to be protonated (i.e. able to bind two carboxylic 
acids), their use allows the application of substoichiomeric amounts of CSA. The ability of 
amino alcohols such as 2-[(2R)-2-hydroxy-3-[[(1S)-1-phenylethyl]amino]propyl]-
isoindoline-1,3-dione (57)152 to resolve the enantiomers of carboxylic acids has been 
examined.152,153 Cyclic amines such as the aminonaphthol based macrocyclic amine 
(58)154 and ‘calixarene-like’ compound trianglamine (59)155,156 have been developed and 
their ability in enantiomeric recognition has been promising. Cyclic amines have been 
commonly applied in the enantiomeric separation of carboxylic acids154,156-158, however, 
also alcohols155 have been studied. 
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Figure 13. A diamine, molecular tweezers, an amino alcohol and cyclic amines. 
 
Amine based CSAs are excellent for studying enantiomeric purity of carboxylic acids 
as they form a diastereomeric salt complex. If both the amine and studied substrate contain 
hydrogen bonding elements and the aromatic moiety, the formed complex is better 
stabilised, increasing the chemical shift difference of the enantiomeric nuclei. If salt 
complex formation is not possible (e.g. in the case of alcohols) the amine moiety still 
provides a site for hydrogen bonding  (Fig. 14). In the case of primary and secondary 
amines it is also possible to have additional stabilisation, as they are not only hydrogen 
acceptors but also donors.   
                 
 
Figure 14. Examples of possible complex coordination patterns shown in publications.131,151,152  
 
Various carboxylic acids have been used as model compounds to determine the 
resolution ability of synthesised amine CSAs. Generally the model compounds have been 
α-substituted aromatic carboxylic acids, many of them having electronegative group at the 
α-position (OH, OCH3, NHCOCH3 etc.).134,138,140,142,148,150,152,154,156,157 One of the most 
frequently used carboxylic acid is mandelic acid. Comparison between a few amine based 
CSAs reported in the literature (Table 2) shows major differences in their enantiomeric 
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resolution power. Mandelic acid is resolved best by the BINOL based 47 and the cyclic 
amine 58. As in general the structure of the CSA is mainly responsible of the resolution of 
enantiomers, the advantage of these two is that they can cause shielding and are also able 
to stabilise the formed complex better than the other CSAs as they contain hydrogen donor 
and acceptor groups. The cyclic amine 58 has even an advantage over 47 in that it has two 
binding sites (i.e. two secondary amine groups) and therefore can bound to both of the 
enantiomers of the acid at the same time, which reduces the need of CSA (host:guest 
ration 1:2 vs. 2:1).  
 
Table 2. Comparison between some amine CSAs with racemic mandelic acid (1H NMR, all 
measured in CDCl3).  
 
Host Δδ  (ppm) Δδ  (Hz) Conditionsa Ref. 
45 0.005 2.0 1:1 host:guest, 400 MHz 134 
47 0.284 142.0 2:1 host:guest, 500 MHz 138 
48 0.071 28.4 1:2 host:guest, 400 MHz 140 
50 0.010 4.0 1:1 host:guest, 400 MHz 142 
55 0.042 21.0 3:1 host:guest, 500 MHz 148 
56 0.020 6.0 1:1 host:guest, 300 MHz 150 
57 0.019 7.6 1:1 host:guest, 400 MHz 152 
58 0.620 310.0 1:2 host:guest, 500 MHz 154 
59 0.044 17.6 1:3 host:guest, 400 MHz 156 
          a Depending on the complexation pattern the host:guest ratio varies between CSAs. 
2.2.3 Ionic CSAs 
The interest towards ionic liquids, especially their sub-class, chiral ionic liquids 
(CILs), has increased the attraction towards ionic CSAs.159 The ability to tune the 
properties of CILs (or in general ionic CSAs) makes them attractive as their counter anion 
and/or cation composition can be easily modified. Ionic CSAs are suitable for the 
enantiomeric resolution on NMR, although only few studies are available in the literature 
of their use in this application. This may be due to the consideration of their resolution 
ability, especially with the CIL based CSAs, being lower than with the non-ionic ones.160 
Some of the CIL based CSAs introduced in this chapter have been developed for other 
purposes than CSAs, but their ability to recognise161-164 and/or induce165,166 chirality has 
been studied on NMR spectroscopy. It is an easy and trouble free technique to find out if a 
compound can be utilised as catalyst in asymmetric synthesis165,167,168 or in analytical 
applications able to detect chirality.161-164,169  
 
As with non-ionic CSAs the resolution of enantiomers is based on the formation of 
diastereomeric complex. However, in the case of ionic CSAs the substrate generally has to 
be in an ionic form to be able to form a diastereomeric salt. In the sections 2.2.3.1 and 
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2.2.3.2 the chiral anions and cations of ionic CSAs are given more attention than their 
counter ions that are treated only briefly.  
2.2.3.1 Anionic  CSAs 
The development of anionic CSAs is less common than that of cationic ones. Also the 
small number of anionic CIL based CSAs is surprising as the development of new CILs 
and the study of their application possibilities is a popular research topic. This may be due 
to difficulties in synthesis or the lack of suitable starting materials. This, however, is odd 
as for example chiral carboxylic acids are easily available and cheap (e.g. amino acids) 
and in general chiral anions could be useful in the resolution of chiral amines. A few chiral 
alkali carboxylates such as Mosher’s acid (60) and 2-phenylpropanoic acid (61) 
carboxylates have been used in the resolution of racemic ammonium halides.170 
Dimethylaminopyridinium mandelate (62) has been employed in the enantioseparation of 
cyanohydrins and carboxylic acids.39 Also the discrimination ability of the sulfate 
derivative of (-)-menthol (63) and of (+)-fenchol (64) has been investigated.171   
 
Chiral borate anions 65,172 66173 and 67174 have been studied in the discrimination of 
racemic copper(I) complexes,173 and triphenylphosphonium salts174. The well known 
anionic CSAs are chiral hexacoordinate phosphate anions such as 
tris(tetrachlorobenzenediolato)phosphate (TRISPHAT, 68) and bis(tetrachloro-
benzenediolato)mono([1,1’]binaphthalenyl-2,2’-diolato)phosphate (BINPHAT). They 
have been used in the enantiomeric resolution of racemic quaternary amine cations,175 
quaternary phosphonium cations,176,177 tricarbonylchromium coplexes178  and ruthenium 
bis(diimine) complexes179. A few different type anionic CDs, such as carboxymethylated 
CD derivatives (69), have been developed and found to be more efficient for cationic 
substrates than native CDs.30,180 
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Figure 14. Miscellaneous anionic CSAs. 
 
The counter cation of anionic CSA can be varied. Quite commonly the counter cation 
used has been the tetrabutyl ammonium (n-Bu4N+) cation.171,175-179 The organic cations are 
beneficial as they will ease the dissolving in low-polarity solvents. Also sodium,170,181 
pyridinium,171 ammonium,171 protonated amines,171,174 tetrabutylphosphonium (n-
Bu4P+)171 and 1-butyl-3-methylimidazolium (BMIM+)171,172 have been used as counter 
ions for anionic CSAs (Fig. 15).  
 
 
 
Figure 15. Various counter cations used with anionic CSAs. A Sodium, ammonium and pyridinium 
cations, B protonated amine cations, C tetrabutylammonium (n-Bu4N+) and 
tetrabutylphosphonium (n-Bu4P+) cations and D 1-butyl-3-methylimidazolium cation (BMIM+). 
OSO3
OSO3
P
O O
O
O
O O
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
Cl
O
O
B
O
O O
O
O
O
O
O
O
O
B
B
O
B
O
O
O O
O
H
O
O
H3CO CF3
O
O
O
O
OH
O
HO
OO2CH2C
OH
n
α-CD: n=6
β-CD: n=7
γ-CD: n=8
CH2CO2
OH
60
63
62
6665
6968
61 64
67
N
P
NN
N
H
NH4Na NH2
N
H2
A
D
CB
 
 
 
 
29 
2.2.3.2 Cationic CSAs 
Several cationic CSAs have been developed. A common feature is that they contain a 
positively charged nitrogen unit. Since the number of cationic CSAs developed is not very 
large and as usually only one model compound has been used for the demonstration of the 
enantiomeric discrimination ability it is difficult to make conclusions which cation types 
are optimal (e.g. imidazolium vs. ammonium). Also only in a few studies the ability of 
cationic CSAs to resolve a variety of different compounds has been investigated.  
Generally the most studied compound classes include carboxylic acids182-184 and 
alcohols.182,185 With cationic CDs the investigation has focused on carboxylic acids and 
amino acids.181,186 In general it can be stated that cationic CSA may be good for anionic 
substrates. They suit poorly for non-ionic ones, but if the CSAs contain polar functional 
groups (e.g. amine) they may induce good resolution.  
 
Most of the cationic CSAs are based either on the imidazolium or 2-imidazolinium 
(4,5-dihydroimidazolium) unit and they usually contain groups, such as hydroxyl group, 
able to form hydrogen bonding as in 70,165 71,165 72187 and 73188. Other popular functional 
groups have been ether (74189 and 75168) and amine (76190). Also zwitterionic CSAs such 
as 77182 and CSAs containing two 2-imidazolinium units as in 78 and 79 have been 
developed.167 
 
 
Figure 16. Imidazolium, 2-imidazolinium and bisimidazolinium CSA cations. 
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Ammonium based CSAs are less common than imidazolium ones. Ammonium CSA 
can be either a quaternised tertiary amine such as isomannide based CSAs 80191 and 81192, 
ephedrine based CSA 82185 and 83166 and (S)-(-)-(3-chloro-2-
hydroxypropyl)trimethylammonium (84)187 or protonated primary (85161, 86170 and 87164), 
secondary (88161 and 89193) or tertiary amine (90161).  
 
 
Figure 17. Ammonium CSA cations. 
 
Also other types of CSAs containing an ionic nitrogen unit have been developed such 
as pyridinium (91194, 92195 and 93185), pyrrolidine (94169 and 95185), thiouronium (96184) 
and thiazoline (97196) based CSAs. Also cationic cyclodextrins have been developed such 
as those with an ammonium186 and quaternary amine unit (98)181.   
 
 
Figure 18. Pyridinium, pyrrolidine, thiouronium, thiazolidine and CD based CSA cations. 
 
The common counter anions for cationic CSAs (Fig. 19) are bromide (Br-),184,185,187,195 
iodide (I-),191,192,194-196 tetrafluoroborate (BF4-),165,169,185,191,192,195 hexafluorophosphate 
(PF6-)167,185,188,191,192,195 and bis(trifluoromethylsulfonyl)imide (NTf2-)161-168,183,184,187-189,191-
193,195. Also others such as hexafluoroantimonate (SbF6-),187 tetrakis(3,5-
bis(trifluoromethyl)phenyl)borate (B[3,5-(CF3)2-C6H3]4-),165,167 trifluoro methane 
NH3
OH
NH2
OH
N
H
OH
N
OH
O
O
O
NH
H
CH2Ph
O
O
N
NH
H
CH2Ph
PhH2C
N Cl
OH
N
H2NH3
O
O
N
OH
(CH2)11
Si
OCH3H3CO OCH3
NH3
85
828180
83 84
86 87 908988
N
N N
(CH2)3
Si
H3CO OCH3OCH3
H
N
H
N
O
O
O
N (CH2)11N C12H25Bn
HO OH
OH
OCH3H3CO OCH3
N
S N
N
H
N
H
S
H H O
HO
O
OH
N
n
OH
Nα-CD: n=6
β-CD: n=7
γ-CD: n=896 97 98
95
94939291
 
 
 
 
31 
sulfonate (TfO-)191,192,194 and trifluoroacetic carboxylate (TFA-)191,192,194 have been 
applied. NTf2- is by far the most commonly used counter anion with CIL based CSAs. 
 
 
 
Figure 19. Examples of used counter anions for cationic CSAs. A Bromide and iodide anions, B 
tetrafluoroborate (BF4-), hexafluorophosphate (PF6-) and hexafluoroantimonate (SbF6-) anions, C 
bis(trifluoromethylsulfonyl)imide (NTf2-), trifluoromethane sulfonate (TfO-) and trifluoroacetic 
carboxylate (TFA-) anions and D tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (B[3,5-(CF3)2-
C6H3]4-) anion. 
 
When the enantiomeric discrimination ability of cationic CSAs has been studied 
MTPA has been favoured as a model compound. It has been applied both in non- 
ionic182,190,193-195 but most often in ionic form as its potassium (K+)161,165,167-169,185,187-189 or 
sodium (Na+)162-164,166 salt. Due to the poor solubility of the potassium and sodium salts of 
MTPA in low polarity solvents additives such as crown ether (e.g. 18-crown-6) have been 
used. Also a more polar solvent (e.g. acetone-d6)165,167,187 or a co-solvent (e.g. DMSO-
d6)164 have been used. The use of an organic counter cation such as tetrabutylammonium 
(n-Bu4N+)184 or triethylammonium (Et3HN+)183 can be applied to make the ionic substrate 
more soluble in non-polar solvents. Commonly, when studying the enantiomeric 
resolution ability of cationic CSAs the measurements have been performed in low-polarity 
solvents such as CDCl3 or CD2Cl2 using the host:guest ratios 1:1163-165,167,169,182,197 or 
2:1168,183,195.  However, higher ratios such as 3:1,169,187,189 4:1,191 and 5:1161,185 have been 
used and ratios even as high as 8:1,193 10:1194 and 23.7:1162 have been applied. The highest 
resolution of the enantiomers of Mosher’s acid (Table 3) has been obtained with 2-
imidazolinium bearing CSAs such as 70, 73 and 79. The anion has an effect on the Δδ, and 
in general the delocalised charge in anion (e.g. NTf2-) increases the Δδ compared to others, 
especially those with more localised charge (e.g. Cl- and Br-).  It is also encouraging to 
notice that some cationic CSAs are able to resolve non-ionic compounds. The common 
feature in these CSA cations, 77 and 92, is that they contain an amine group that is 
protonated by the acid leading to the formation of a diastereomeric salt.   
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Table 3. Comparison between cationic CSAs with racemic Mosher’s acid (MTPA). (‘Conditions’ 
indicate the form of MTPA, the host:guest ratio (in parentheses), possible additive and its amount 
(in parentheses), solvent used and field strength(s)) (- spectra was not measured)  
 
CSA Δδ  (ppm (Hz)) 
Conditions Ref 
Cation Anion 19F 1H 
70 
BF4- 
NTf2- 
B[3,5-(CF3)2-C6H3]4- 
0.0 
0.31 (118.0) 
0.40 (151.0) 
0.0 
0.030 (12.0) 
0.060 (24.0) 
K+MTPA- (1:1), d6-Acetone, 1H 
400 MHz, 19F 378 MHz 
165 
      
71 BF4- 0.085 (32.0) 0.0 
K+MTPA- (1:1), d6-Acetone, 1H 
400 MHz, 19F 378 MHz 
165 
      
72 
Br- 
SbF6- 
NTf2- 
0.0 
0.0 
0.023 (8.7) 
0.019 (7.6) 
0.017 (6.8) 
0.026 (11.2) 
 
K+MTPA- (3:1), CD3CN, 1H 400 
MHz, 19F 376 MHz 
 
187 
      
73 PF6- 0.168 (63.0) 0.15 (60.0) 
K+MTPA-  (3.3:1), 18-crown-6 (1 
eq), CD2Cl2 , 1H 400 MHz, 19F 376 
MHz 
188 
      
74 NTf2- 0.026 (7.3) - 
K+MTPA- (3:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 282 MHz 
189 
      
75 
 
NTf2- 
 
 
0.081 (15.1) 
 
 
0.0 
 
K+MTPA- (2:1), 18-crown-6, 
CDCl3, 1H MHz 200, 19F 188 MHz 
168 
 
      
77 No anion - 0.090 (36) MTPA (1:1), CDCl3, 1H 400 MHz 182 
      
78 
NTf2- 
B[3,5-(CF3)2-C6H3]4- 
0.072 (27.1) 
0.035 (13.0) 
0.011 (4.3) 
0.0 
K+MTPA- (1:1), Acetone-d6, 1H 
400 MHz, 19F 376 MHz 
167 
      
79 
PF6- 
B[3,5-(CF3)2-C6H3]4- 
0.14 (53.0) 
0.050 (18.8) 
0.016 (6.3) 
0.0 
K+MTPA- (1:1), Acetone-d6, 1H 
400 MHz, 19F 376 MHz 
167 
      
82 Br
- 
BF4- 
0.042 (10.0) 
0.046 (10.8) 
- 
K+MTPA- (5:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 236 MHz 
185 
 
      
85 
 
NTf2- 
 
0.054 (12.7) - K
+MTPA- (1:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 236 MHz 
161 
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89 NTf2- 0.044 (11.0) - 
Na+MTPA- (1:1), CD2Cl2 with 
30% DMSO-d6, 19F 236 MHz 
164 
      
88 NTf2- 0.024 (5.7) - 
K+MTPA- (1:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 236 MHz 
161 
 
      
90 NTf2- 0.018 (4.3) - 
K+MTPA- (1:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 236 MHz 
161 
 
      
91 
TfO- 
TFA- 
I- 
0.008 (4.1) 
0.005 (2.4) 
0.0 
- 
n-Bu4N+MTPA- (10:1), CD2Cl2, 19F 
470 MHz 
194 
      
92 
I- 
NTf2- 
PF6- 
BF4- 
0.021 (5.9) 
0.032 (9.0) 
0.0 
0.026 (7.2) 
0.015 (7.5) 
0.040 (20.0) 
0.013 (6.5) 
0.020 (10.0) 
MTPA (2:1), CDCl3, 1H 500 MHz, 
19F 282 MHz 
195 
      
93 
Br- 
BF4- 
PF6- 
0.062 (14.7) 
0.052 (12.2) 
0.057 (13.5) 
- 
K+MTPA- (5:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 236 MHz 
185 
 
      
94 BF4- 0.032 (6.1) - 
K+MTPA- (1:1), 18-crown-6, 
CDCl3, 19F 188 MHz 
169 
      
95 BF4- 0.015 (3.5) - 
K+MTPA- (5:1), 18-crown-6 (1.0 
eq), CDCl3, 19F 236 MHz 
185 
 
      
96 NTf2- 0.045 (12.7) 0.091 (27.3) 
n-Bu4N+MTPA- (1:1), CDCl3, 1H 
300 MHz, 19F 282 MHz 
184 
 
Variations into the commonly used sample preparation conditions have been made. For 
instance, the addition of water has been shown to be beneficial (Table 4). The reason for 
increased resolution is due to the pairing of counter anion of CSA (e.g. BF4-) and counter 
cation of substrate (e.g Na+) which increases ionic interactions between the chiral cation 
and an anionic racemic substrate. If the salt formed from counter ions (e.g. NaBF4) is 
water-soluble it will be transferred to the water phase, reducing the amount of ions in the 
organic solvent. This leads to better interaction between the host cation and guest anion 
leading to an increase in Δδ. The same practice may be used in those cases where the ionic 
substrate is not soluble in CDCl3 but dissolves in water. In this case the substrate solution 
can be prepared in water and then added to an NMR tube containing the host in CDCl3.162 
This way the use of 18-crown-6 can be avoided. Although the addition of water may 
increase the Δδ, some disadvantages may appear. If the guest and/or host are water-
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soluble, they may dissolve in the water phase. The added water may also interfere in the 
hydrogen bonding between the host and guest and weaken interactions.188   
 
Table 4. Experiments where water was added to the NMR sample. (‘Conditions’ indicate the form 
of MTPA, the host:guest ratio (in parentheses), solvent used and field strength)  
 
CSA 19F Δδ  (ppm, (Hz)) Conditions Ref. 
Cation Anion 
76 BF4- 0.093 (35.0) 
MTPA (3.7:1), water-
saturated CD2Cl2, 19F 376 
MHz 
190 
     
83 NTf2- 
0.025 (7.05) 
0.05 (14.1) (H2O) 
Na+MTPA- (9:1), CD2Cl2, 
19F 282 MHz 
166 
     
89 NTf2- 
0.019 (5.4) 
0.028 (7.8) (H2O) 
MTPA (8:1), CD2Cl2, 19F 
282 MHz 
193 
     
 
In a few studies the MTPA was converted to its corresponding CSA salt  
(CSA+MTPA-) on ion-metathesis (e.g. Ag+MTPA- + CSA+I- ! CSA+MTPA- + AgI). The 
cationic CSA was then used for the discrimination of the formed CSA+MTPA- salt (Table 
5). As in the case of water addition, the amount of the counter ions (anion of CSA and 
cation of MTPA) can be reduced in the solution investigated. However, compared to water 
addition this method is more time consuming and wastes the precious CSA. 
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Table 5. The experiments with ion metathesis. (‘Conditions’ indicate the form of MTPA, the 
host:guest ratio (in parentheses), solvent used and field strength)  
 
CSA 19F Δδ  (ppm, (Hz))  Conditions Ref. 
Cation Anion 
80 
I- 
NTf2- 
PF6- 
TFA- 
BF4- 
TfO- 
0.032 (9.0) 
0.081 (23.0) 
0.074 (21.0) 
0.028 (8.0) 
0.060 (17.0) 
0.053 (15.0) 
CSA+MTPA- (4:1), CD3CN, 
19F 282 MHz 
191 
     
81 
I- 
NTf2- 
PF6- 
TFA- 
BF4- 
TfO- 
0.025 (7.0) 
0.032 (9.0) 
0.028 (8.0) 
0.018 (5.0) 
0.018 (5.0) 
0.032 (9.0) 
CSA+MTPA- (3.5:1), 
CD3CN, 19F 282 MHz 
192 
     
97 I- 0.047 (11.0) 
CSA+MTPA-, (5:1), 
H2O+C6D6, 19F 235 MHz 
196 
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3 The effect of conditions of measurement and sample 
preparation on the enantiomeric resolution in NMR 
spectroscopy 
The shape (e.g. bulkiness, functional groups etc.) of the substrate and CSA have a 
major effect on the success of complex formation. However, several external matters can 
improve or worsen the discrimination of enantiomers. A deuterated solvent, host:guest 
ratio, temperature and the counter ions of CSA and guest have an effect on Δδ.19,191 In this 
section, the effects of conditions of measurement and sample preparation are explored on 
the perspective of cationic CSAs. Just to note, solvent, host:guest ratio and temperature 
have similar effects in those cases where non-ionic CSAs are used.  
3.1 Solvent 
Solvent plays a crucial role in NMR discrimination experiments.6,18,185 Especially 
when ionic compounds are studied or when the formation of an ionic complex is expected, 
the polarity of the solvent has significant effect on the resolution of enantiomers (Table 6), 
and it has been noticed to weaken the electrostatic interactions between the host and guest. 
As a result of weaker electrostatic interactions, cations and anions tend to behave as 
dissociated ion pairs leading to a sharp decrease in the enantiodifferentiation.19 Also a 
protic nature of the solvent causes the solvation of ions and interference in hydrogen 
bonding which may disturb the complex formation.171,182,183,195 Thus the favoured solvent 
in NMR resolution experiments has been CDCl3 which is not only weakly polar but is also 
able to dissolve a variety of compounds (even ionic ones). However, opposite effects have 
also been detected and occasionally the use of a more polar solvent can be 
advantageous.195 This may indicate that there are hydrophobic interactions between non-
polar groups of the CSA and substrate which are promoted by a polar solvent. 
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Table 6. The effect of solvent on the magnitude of non-equivalence (Δδ).171,182,195 
 
CSA Substrate Solvent Polaritya198 Δδ ,19F (Hz)b Ref. 
 
 
CDCl3 25.9 7.5 
195 
CD3OD 76.2 4.3 
      
  
Toluene-d8 9.9 40.6 
171 
CDCl3 25.9 19.2 
      
  
Toluene-d8 9.9 30 
182 
CDCl3 25.9 15 
CD2Cl2 30.9 5.7 
CD3CN 46.0 0.0 
CD3OD 76.2 0.0 
a Polarity index values are for non-deuterated solvents. b Conditions in ref 195 282 MHz; in ref. 171 375 MHz; in ref. 182 
378 MHz. 
3.2 Host:Guest ratio 
High concentrations of the CSAs generally enhance the discrimination of enantiomers.18,19 
This is postulated to be due to the ability of additional CSA to push complexation 
equilibrium to the right (Scheme 1 (1)). However, the use of CSA over the stoichiometric 
amount does not always drastically increase the Δδ.166,191,192 The application of 
substoichiometric amounts of the CSA does not necessarily lead to a lack of 
discrimination. In the NMR timescale the equilibrium is often under fast exchange 
(Scheme 1 (2)) yielding population-averaged spectra of the complex and the free 
enantiomer signals. This results in distinct signals for the two enantiomers.199 Since CSA 
synthesis is time consuming and commercial CSAs are expensive it is desirable to use 
sub-stoichiometric or stoichiometric amounts of CSA instead of an excess.2 This is not 
only economically preferable but also avoids additional spectral complexity. As the 
enantiomeric recognition is induced by the formation of a complex, the composition of the 
complex (e.g. 2:1 complex vs. 1:1 complex) defines how much CSA is needed. The 
composition is generally determined by titration and Job’s plot.184 
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(1) 
 
(2) 
 
Scheme 1. The equilibrium between CSA and the R and S enantiomer (1) and the equilibrium 
between free and bound enantiomer including a change of enantiomer bound to CSA (2).            
3.3 Temperature 
Temperature also affects the strength of the interactions between the solvating agent 
and a racemic substrate. In general, lower temperatures decrease the exchange rate leading 
to increased Δδ (respectively, higher temperatures decrease the Δδ). A decrease of 
temperature increases the magnitude of non-equivalence in two ways as it increases the 
association constant of the CSA-substrate complex and by a greater restriction of the 
conformational freedom of the CSA and the solute.18,19 A similar increase of the 
differentiation of the enantiomers could be attained by increasing the total concentration of 
the mixture.19 
3.4 Anion of cationic CSA 
The counter anion of the cationic CSA has a crucial role in the host:guest 
coordination.189,191,192 The coulombic interaction between an ionic CSA and the racemic 
guest is stronger when the interaction between the cation and anion of CSA is weak.191,192 
Coulombic interactions between the ions in CSA can be minimized by distributing the 
charge over several atoms. For instance, good anions with delocalised charge are TFA-, 
TfO- and NTf2- as the charge is delocalised through the O-C-O, O-SO2 and S-N-S-core, 
respectively (Fig. 20).192 In general, the more delocalised anions give better results 
regardless of solvent, the cation of CSA or the form of the substrate (Table 7). However, 
this does not apply in all cases.167,185,187,188 Also the effect of hydrophobicity (e.g. Cl- vs. 
NTf2-) or steric size (e.g. BF4- vs. B[3,5-(CF3)2-C6H3]4-) of the anion may have an 
influence.185   
  
 
Figure 20. Delocalisaton of negative charge in A TFA-, B TfO- and C NTf2- anions.192 
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Table 7. The effect of anion on the magnitude of non-equivalence (Δδ) of cationic CSA. 
 
CSA 
Δδ , 19F (Hz) Solvent 
Substrate and  
additive 
Ref. 
Cation Anion 
 
Br- 9.95 
CDCl3 
K+MTPA-,  
18-crown-6 
185 BF4- 10.76 
PF6- 0.0 
      
 
BF4- 0.0 
Acetone-d6 K+MTPA- 167 B[3,5-(CF3)2-C6H3]4- 151 
NTf2- 118 
      
 
B[3,5-(CF3)2-C6H3]4- 13.0 
Acetone-d6 K+MTPA- 165 
NTf2- 27.1 
      
 I- 5.9 
CDCl3 MTPA 195 
NTf2- 9.0 
BF4- 7.2 
PF6- 0.0 
      
 
Br- 0.0 
CD2CN 
K+MTPA-,  
18-crown-6 
187 SbF6- 0.0 
NTf2- 8.7 
3.5 Cation of guest 
The racemic substrate can be in a non-ionic or an ionic form. The use of an ionic 
substrate is favoured as in this case the substrate can ‘replace’ the counter ion of CSA, 
leading to increased ionic interactions between the CSA and substrate. Even though the 
effect of counter cation is known its effect has rarely been studied. As mentioned in 
chapter 2.2.3.2 several different counter cations have been used, potassium in particular. 
The use of sodium or potassium as the counter ion causes solubility problems which are 
usually solved by the addition of crown ether161, 185 or using a more polar solvent (e.g. 
acetone-d6165,167, CD3CN187, CD2Cl2188, DMSO-d6163). Also the possibility to use organic 
cations such as triethylammonium (Et3HN+) and tetrabutylammonium (n-Bu4N+) cations 
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has been studied.183,184 These bulkier and more hydrophobic cations can provide an 
analysis procedure without additives or a need for more polar solvent. The size of the 
cation of a racemic substrate has also been noticed to have an effect (e.g. potassium vs. 
sodium). The bulkier the cation the smaller the attractive forces (due to increased charge 
distance) between the ionic substrate and the anion.188 Increased interaction between the 
CSA and the racemic substrate will lead to a higher Δδ. 
 
 
 
 
41 
4 Aim of the study 
The objective of the research was to develop new CSAs for the enantiomeric 
recognition of chiral carboxylic acids by NMR spectroscopy.  
 
The specific aims of the study were 
 
1. To synthesise CSAs suitable for the enantiomeric discrimination of chiral α-
substituted carboxylic acids (I, II, III, V, VI) 
 
2. To screen the enantiomeric recognition ability of the CSAs developed in NMR 
with selected chiral model compound (I, II, III, V) 
 
3. To subject the best CSA candidates to a comprehensive study to establish their 
applicability for this purpose by testing their chiral recognition capacity with a 
wide variety of α-substituted carboxylic acids (I, II, III) 
 
4. To study the effects of NMR sample preparation and NMR measurement 
conditions to the magnitude of non-equivalence when using ionic CSAs (IV) 
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5 Results and discussion 
The aim of the research has been to develop ionic and non-ionic CSAs capable of 
resolving enantiomers of chiral carboxylic acids. Since chiral carboxylic acids are basic 
building blocks for many biological molecules, natural products and medicinally 
important compounds, such applications are welcome. As chiral carboxylic acids can form 
diastereomeric salts with chiral amines, amine based CSAs were developed.  The use of 
cationic CSAs was also investigated, as they have not been widely studied. Cl-, Br-, BF4- 
and NTf2- were chosen as counter anions for cationic CSAs, since they are the most 
common, especially among CIL based CSAs. The enantiomeric resolution of non-ionic 
guests by CIL based CSAs has been rarely studied and commonly the guest has been 
converted to ionic form. In this study we wanted to see if the developed cationic CSA can 
discriminate also non-ionic species, if the anion has an effect on the resolution and if the 
effect is the same for ionic and non-ionic guests. 
 
As commercially available CSAs are usually expensive, the development of cheap and 
easily available CSAs is preferred. In our research tedious reaction steps and expensive 
starting materials were generally avoided and usually the synthetic routes contained only a 
few steps. We have used the resin acid derivative (+)-dehydroabietylamine (99) as starting 
material for the synthesis of new CSAs. As (+)-dehydroabietylamine is readily available, 
has an aromatic moiety, is bulky and has an amine group that can be converted to ionic 
form, and is known to have chiral recognition ability towards chiral carboxylic acids200,201 
it provides an ideal starting material for the synthesis of CSA. 
5.1 Synthesis of chiral solvating agents (I, II, III, V, VI) 
5.1.1 Ammonium CSAs 
The synthesis of ammonium based CSAs were performed in two steps (Scheme 1). 
First, (+)-dehydroabietylamine (99) was reacted with formaldehyde to form the tertiary 
amine 100. 100 was quaternised with an alkyl halide to obtain 102-104. In order to tune 
the physical and binding properties, anion exchanges were conducted (105-110). 
Compound 100 was also converted to an ionic form by protonating it with 
bis(trifluoromethane)sulfonimide (HNTf2) to give 101.  
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Scheme 2. Synthesis of chiral ammonium based CSAs from (+)-dehydroabietylamine. (MY=LiNTf2 
or NH4BF4) 
5.1.2 Secondary amine CSAs 
Secondary amine derivatives of 99 were prepared, and all of the derivatives (111-115) 
as well as 99 were converted to NTf2- salts (116-121). NTf2- was chosen as the counter 
anion as it is known to enhance enantiomeric resolution when using ionic CSAs. 
Compounds 112-115 were prepared in a microwave reactor by a one-step reaction 
(Scheme 3). The synthesis of compound 111 consisted on two steps, 99 being first 
converted to the formamide that was reduced to the secondary amine (111). 
 
 
Scheme 3. Preparation of (+)-dehydroabietylamine based secondary amines and their 
corresponding NTf2- salts. (DAB = (+)-dehydroabietylamine; BrR = BrEt, Br(CH2)2OH, 
Br(CH2CH2O)2Me, Br(CH2)2Br) 
5.1.3 Imidazolium CSAs 
(+)-Dehydroabietylmidazolium based CSAs were synthetised for the first time in our 
laboratory. The synthesis of 122 and 127 were performed as a one-pot reaction. 
Compound 130 was made in two steps by first preparing N1,N2-bisdehydroabietylethane-
1,2-diamine, then reacted with triethylorthoformate (HC(OEt)3) and ammonium 
tetrafluoroborate (NH4BF4) to obtain dihydroimidazolium compound 130. N-
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Benzylimidazolium 124 was made by quaternising 122 with benzylbromide. Compound 
122 was protonated with HNTf2 to yield 123. To obtain compounds 125, 126, 128, 129 
and 131 anion exchanges were performed. 
 
 
Scheme 4. Synthesis of (+)-dehydroabietylimidazolium based CSAs (122-131).  
5.2 The use of the synthetic compounds as CSAs in NMR 
spectroscopy measurements (I, II, III, V) 
Mosher’s acid (MTPA, 1) was the first choice as model compound in the investigation 
of enantiomeric discrimination ability of synthetic CSAs. It has the advantage over 
mandelic acid (common with non-ionic CSAs) that the CF3 group enables the use of both 
1H and 19F NMR. It is also the most commonly exploited model compound in the 
resolution ability studies of ionic CSAs. All the synthetic compounds were tested as CSAs 
using MTPA and its tetrabutylammonium (n-Bu4N+) salt (132). 
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Figure 21. MTPA (1) and its tetrabutylammmonium salt (132). 
 
The effect of the concentration of CSA was also investigated as it has been noted that 
higher CSA concentrations may enhance resolution.18,19 CDCl3 was chosen as solvent for 
the experiments as weakly polar solvents do not interfere in the complex formation. All 
experiments were performed in the same manner by taking 0.5 mL (1.0 eq, 22.0 mM) of 
stock solution containing MTPA or n-Bu4N+MTPA- (guest) where the CSA (host) (1.0 or 
2.0 eq) was dissolved. Both 1H and 19F NMR spectra were recorded. Table 8 presents the 
results from ammonium series (100-110), Table 9 from the secondary amine series (99 
and 111-121) and Table 10 from the imidazolium series (122-131).  
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Table 8. Determination of the magnitude of non-equivalence (Δδ) with Mosher’s acid and its n-
Bu4N+ salt as model compounds in the presence of various ammonium based CSAs (100-110), 
using both 1H (500 MHz) and 19F NMR (470 MHz) in CDCl3 at 27 °C.  
 
CSA Host:Guest 
MTPA (ppm, (Hz)) n-Bu4N+MTPA- (ppm, (Hz)) 
1H 19F 1H 19F 
100 
1:1 0.036 (18.1) 0.12 (58.5) 0.0018 (0.9) 0.0 
2:1 0.042 (21.6) 0.15 (71.7) 0.0 0.0 
101 
1:1 0.0 0.0 0.030 (15.0) 0.10 (48.3) 
2:1 0.0 0.0 0.026 (13.1) 0.12 (54.2) 
102 
1:1 0.0 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.0 
103 
1:1 0.0 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.015 (6.8) 
104 
1:1 0.0 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.0 
105 
1:1 0.0 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.0 
106 
1:1 0.027 (1.3) 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.0 
107 
1:1 0.0015 (0.8) 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.0 
108 
1:1 0.0017 (0.9) 0.0 0.0037 (1.9) 0.0 
2:1 0.0 0.0 0.010 (5.1) 0.018 (8.3) 
109 
1:1 0.0 0.0 0.0 0.0 
2:1 0.0 0.0 0.0 0.0 
110 
1:1 0.0017 (0.9) 0.0 0.0052 (2.6) 0.0 
2:1 0.0 0.0 0.016 (8.2) 0.0 
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Table 9. Determination of the magnitude of non-equivalence (Δδ) with Mosher’s acid and its n-
Bu4N+ salt as model compounds in the presence of various secondary amine CSAs (99 and 111-
121) using both 1H (500 MHz) and 19F NMR (470 MHz) in CDCl3 at 27 °C.  
 
CSA Host:Guest 
MTPA (ppm, (Hz)) n-Bu4N+MTPA- (ppm, (Hz)) 
1H 19F 1H 19F 
99 
1:1 0.024 (12.1) 0.074 (34.6) 0.0 0.0 
2:1 0.022 (10.9) 0.064 (30.3) 0.0 0.0 
111 
1:1 0.037 (18.7) 0.0 0.0 0.0 
2:1 0.04 (20.0) 0.029 (13.5) 0.0 0.0 
112 
1:1 0.013 (6.7) 0.0 0.0 0.0 
2:1 0.016 (7.8) 0.0 0.0 0.0 
113 
1:1 0.0059 (3.0) 0.017 (8.0) 0.0 0.0 
2:1 0.0092 (4.6) 0.0066 (3.1) 0.0 0.0 
114 
1:1 0.015 (7.5) 0.0 0.0 0.0 
2:1 0.013 (6.3) 0.0 0.0 0.0 
115 
1:1 0.14 (71.8) 0.045 (21.2) 0.0 0.0 
2:1 0.027 (12.3) 0.028 (13.3) 0.0 0.0 
116 
1:1 0.0 0.0 0.014 (6.8) 0.051 (23.9) 
2:1 0.0 0.0 0.016 (8.0) 0.059 (27.7) 
117 
1:1 0.0 0.0 0.033 (16.6) 0.019 (8.7) 
2:1 0.0 0.0 0.025 (12.7) 0.0 
118 
1:1 0.0 0.0 0.014 (6.9) 0.0 
2:1 0.0 0.0 0.0074 (3.7) 0.0 
119 
1:1 0.0 0.0 0.0051 (2.5) 0.0 
2:1 0.0 0.0 0.0068 (3.4) 0.0 
120 
1:1 0.0 0.0 0.0082 (4.1) 0.0 
2:1 0.0 0.0 0.014 (6.8) 0.0 
121 
1:1 0.023 (11.3) 0.035 (16.6) 0.16 (81.1) 0.076 (35.8) 
2:1 -a -a 0.038 (22.2) 0.32 (149.9) 
a Could not be measured since 121 is not soluble in CDCl3  in a high concentration.  
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Table 10. Determination of the magnitude of non-equivalence (Δδ) with Mosher’s acid and its n-
Bu4N+ salt as model compounds in presence of various imidazolium based CSAs (122-131) CSAs, 
using both 1H (500 MHz) and 19F NMR (470 MHz) in CDCl3 at 27 °C. 
 
CSA Host:Guest 
MTPA (ppm, (Hz)) n-Bu4N+MTPA- (ppm, (Hz)) 
1H 19F 1H 19F 
122 
1:1 0.0092 (4.6) 0.031 (14.8) 0.0 0.0 
2:1 0.011 (5.7) 0.041 (19.3) 0.0 0.0 
123 
1:1 0.002 (0.99) 0.0 0.0044 (2.2) 0.024 (11.4) 
2:1 0.0 0.0 0.0042 (2.1) 0.026 (12.2) 
124 
1:1 0.0 0.0 0.0 0.028 (13.4) 
2:1 0.0 0.0 0.0 0.033 (15.7) 
125 
1:1 0.0 0.0 0.0 0.034 (15.7) 
2:1 0.0 0.0 0.0 0.036 (17.0) 
126 
1:1 0.0017 (0.8) 0.0 0.0 0.034 (15.8) 
2:1 0.0 0.0 0.0 0.032 (15.3) 
127 
1:1 0.0056 (2.8) 0.0 0.0 0.074 (35.0) 
2:1 0.0091 (4.5) 0.0 0.0 0.080 (37.7) 
128 
1:1 0.0071 (3.5) 0.0 0.0 0.092 (43.5) 
2:1 0.0099 (5.0) 0.0 0.0 0.102 (47.9) 
129 
1:1 0.002 (1.0) 0.0 0.0029 (1.5) 0.110 (49.8) 
2:1 0.0 0.0 0.0061 (3.0) 0.110 (49.9) 
130 
1:1 0.0 0.007 (3.3) 0.0 0.060 (28.1) 
2:1 0.0 0.015 (7.0) 0.0 0.077 (36.4) 
131 
1:1 0.0019 (1.0) 0.0 0.0 0.065 (30.6) 
2:1 0.0 0.0 0.0 0.074 (34.7) 
 
The non-ionic CSAs give the best resolution for MTPA and ionic CSAs for the n-
Bu4N+MTPA-. This is due to the formation of a diastereomeric salt between MTPA and 
non-ionic CSA, and between MTPA carboxylate and cation of CSA. As diastereomeric 
salt cannot be formed between ionic and non-ionic species the interaction between the host 
and guest remains low leading to poor enantiomeric resolution. The effect of the anion of 
CSA was observed and usually the more delocalised anion (NTf2-) gave the best 
resolution. However, in the case of imidazolium CSAs the BF4- anion gave better results 
when the concentration of CSA was increased (CSAs 125 and 130). The increase of CSA 
concentration was not seen to significantly increase resolution. However, in the case of 
100, 101, 104, 108, 121 (in 19F NMR) and 130 notable increases were detected. In the case 
of CSAs 115 and 121 (in 1H NMR) the resolution efficiencies were seen to drastically 
decrease due to increased CSA concentration.  
 
From the ammonium CSAs series the tertiary amine 100 gave the highest resolution 
with MTPA (18.1 Hz in 1H NMR and 58.5 Hz in 19F NMR) and 101 with n-Bu4N+MTPA- 
(15.0 Hz in 1H NMR and 48.3 Hz in 19F NMR). From the secondary amine CSA series 
115 gave the best resolution to MTPA (71.8 Hz in 1H NMR and 21.2 Hz in 19F NMR) and 
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121 for n-Bu4N+MTPA- (81.1 Hz in 1H NMR and 35.8 Hz in 19F NMR). From the 
imidazolium series CSA 129 gave the best resolution to n-Bu4N+MTPA- (1.5 Hz in 1H 
NMR and 49.8 Hz in 19F NMR). These compounds were chosen for further study (Fig. 
22).  
 
 
Figure 22. The best performing CSAs. 
5.3 Complex stoichiometry, enantiomeric excess and the 
resolution of α-substituted carboxylic acids (I, II, III) 
5.3.1 Titration 
Titration experiments were performed to study how much CSA was needed for 
maximum Δδ and to obtain information about the complex stoichiometry (e.g. 2:1 vs. 1:1 
complex). The guest, MTPA (for non-ionic CSA) or n-Bu4N+MTPA- (for ionic CSA) 
solution was titrated by hosts 100, 101, 115 and 129. Due to poor solubility of 121 in 
CDCl3, titration experiment was performed in opposite manner (i.e. host was titrated by 
guest). The CSAs 100, 101, 121 and 129 gave maximum Δδ at host:guest ratio of 1:1 (Fig. 
23). With host 115 the best molar ratio was 0.5:1 (Fig. 23). Since commercially available 
CSAs are often expensive, the ability of 115 to resolve enantiomers in molar ratio 0.5:1 is 
welcome since generally at least 1.0 eq of host is needed to obtain maximum resolution.19 
The Δδ between the enantiomers of MTPA and n-Bu4N+MTPA- was noticed to decrease in 
1H NMR when the concentration of 101, 115 and 121 was increased. This phenomenon 
may be caused by changes in the complex structure due to increased host concentration or 
aggregation between the molecules. The decrease was very notable in the case of 115. 
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Figure 23. The chiral separation of enantiomers of MTPA with A 100 and C 115 (1H NMR) and 
chiral resolution of enantiomers of n-Bu4N+MTPA- with B 101, D 121 (1H NMR) and E 129 (19F 
NMR). (Concentration of titrated solution was 2.0 mM.) 
5.3.2 Enantiomeric exess 
The applicability of CSAs 100, 101, 115, 121 and 129 in ee measurements was 
investigated. Results indicated that all synthetic CSAs were able to detect the enantiomeric 
purities of samples with excellent reliability (Fig. 24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 24. Enantiomeric purities of MTPA with A 100 and C 115 (1H NMR) and enantiomeric 
purities of n-Bu4N+MTPA- with B 102, D 122 (1H NMR) and E 129 (19F NMR). (Calculated 
regression line with the corresponding equation and correlation coefficient (R2) are also shown) 
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5.3.3 Enantiomeric resolution power 
The ability of synthesised compounds to resolve α-substituted carboxylic acids was 
further investigated with various chiral aromatic and non-aromatic carboxylic acids. The 
non-ionic CSAs 100 and 115 were studied with mandelic acid (3), lactic acid (29), 
ibuprofen (133), ketoprofen (134), N-acetyl-phenylalanine (135), 2-bromopropionic acid 
(136), pyroglutamic acid (137) and (4-hydroxyphenyl)-2-propionic acid (138) (Table 11). 
The cationic CSAs 101, 121 and 129 were investigated with n-Bu4N+ salts of mandelic 
acid (139), lactic acid (140) ibuprofen (141), ketoprofen (142), N-acetyl-phenylalanine 
(143), 2-bromopropionic acid (144) and pyroglutamic acid (145) (Table 12). The best 
enantiomeric resolution was obtained with carboxylic acids having an electronegative α-
substituent, regardless of aromatic or non-aromatic nature of the acid. No major difference 
was observed in the discrimination efficiency between ionic and non-ionic CSAs. 
 
 
Figure 25. α-Substituted carboxylic acids (3, 29, 133-138) used in the enantiomeric resolution 
studies. 
 
 
 
Figure 26. Tetrabutylammoninium salts of α-substituted carboxylic acids (139-145) used in the 
enantiomeric resolution studies. 
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Table 11. The resolution of non-ionic carboxylic acids with CSAs 100 and 115, 1H (500 MHz) in 
CDCl3 at 27 °C. 
 
Carboxylic 
acid 
 
Δδ  with 100 Δδ  with 115 
ppm Hz ppm Hz 
3 H 0.0 0.0 0.084 42.1 
      
29 
H 0.0081 4.1 0.014 6.9 
CH3 0.013 6.4 0.0062 3.1 
      
133 
H 0.0 0.0 0.0052 2.6 
CH3 0.0023 1.1 0.0020 1.1 
i-Pr 0.0 0.0 0.0 0.0 
CH2 0.0 0.0 0.0062 3.1 
      
134 
H 0.0047 2.4 0.0 0.0 
CH3 0.0059 3.0 0.014 7.2 
      
135 
H 0.012 6.1 0.01 5.1 
NH 0.013 6.5 0.052 26.1 
CH3 0.0028 1.4 0.033 16.3 
Ha 0.072 36.2 0.0 0.0 
Hb 0.027 13.4 0.0 0.0 
      
136 
H 0.0 0.0 0.014 6.1 
CH3 0.023 11.5 0.077 38.7 
      
137 
H 0.016 7.9 0.016 8.2 
NH 0.020 10.2 0.088 43.8 
      
138 
H 0.0 0.0 0.008 4.0 
CH3 0.003 1.4 0.014 6.8 
H’Ar 0.0 0.0 0.029 14.4 
HAr 0.0 0.0 0.008 3.81 
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Table 12. The resolution of ionic carboxylic acids with cationic CSAs 101, 121 and 129, 1H (500 
MHz) in CDCl3 at 27 °C. 
 
Carboxylic 
acid 
Δδ  with 101 Δδ  with 121 Δδ  with 129 
ppm Hz ppm Hz ppm Hz 
139 H 0.0 0.0 0.10 50.8 0.0077 3.9 
        
140 
H 0.0068 3.4 0.038 19.1 0.0055 2.8 
CH3 0.017 8.6 -a -a 0.0 0.0 
        
141 
H 0.0 0.0 0.0053 2.6 0.0087 4.4 
CH3 0.0 0.0 0.0099 5.0 0.0 0.0 
i-Pr 0.0 0.0 0.0 0.0 0.0096 4.8 
CH2 0.0 0.0 -a -a 0.006 3.0 
        
142 
H 0.0021 1.0 0.0 0.0 0.0047 2.3 
CH3 0.0041 2.0 0.01 5.1 0.0065 3.2 
        
143 
H 0.012 6.0 0.0 0.0 0.0 0.0 
NH 0.014 6.8 0.051 25.5 0.019 9.7 
CH3 0.0039 1.9 0.033 16.5 0.041 20.6 
Ha 0.065 32.5 0.0 0.0 0.0 0.0 
Hb 0.036 17.8 0.0 0.0 0.0 0.0 
        
144 
H 0.0 0.0 0.016 8.2 0.0033 1.6 
CH3 0.0020 0.9 -a -a 0.0021 1.1 
        
145 
H 0.0030 1.4 0.017 8.4 0.0044 2.19 
NH 0.020 10.0 0.072 36.2 0.0 0.0 
a Peaks overlapped 
 
The usefulness of (+)-dehydroabietylamine based CSAs may cause some concern as 
they have somewhat crowded NMR spectra. However, the possible overlapping of peaks 
with the guest can be minimised by 2D experiments such as HSQC, HMBC and NOESY 
and 1D experiments such as selective TOCSY and carbon selective 1D-HSQC. For 
instance, in the case of 141 the peaks of Ha and Hb overlapped with the peaks of CSA 101 
and the peak resolution was determined using HSQC and NOESY experiments (Fig. 26).  
In some cases the multiplet peaks were not baseline resolved (e.g. 29 and 135) which can 
make ee determination difficult. To solve the problem of poor multiplet resolution, a few 
specialised NMR experiments, allowing homonuclear decoupling (i.e. all multiplets in 1H 
spectrum collapse into a singlet), have been developed such as pure shift experiments,33,34 
J-resolved techniques32 and the quite recently published RES-TOCSY202. The use of a 
modified RES-TOCSY pulse sequence to enhance multiplet resolution in indirectly 
detected dimension was demonstrated with 29 and 135 with CSA 100 (Fig. 27).  
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Figure 27. A HSQC and B NOESY of 143 in the presence of 101 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Modified RES-TOCSY experiment performed to A 29 (Δδ 11.1 Hz, CH3) and B 135 
(Δδ 6.1 Hz, CH) in the presence of CSA 100. 
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5.4 The effect of conditions of measurement and sample 
preparation on the magnitude on non-equivalence (IV) 
The effect of conditions of measurement and sample preparation on the magnitude of 
non-equivalence (Δδ) was examined and the effects of solvent, host:guest ratio, 
concentration and temperature were investigated. Also the effect of the anion of cationic 
CSA and the cation of guest were studied. In this section only the effect of solvent, NMR 
sample concentration, temperature and counter cation of anionic guest are discussed as the 
host:guest ratio and the effect of CSA anion have been previously considered in sections  
5.2 and 5.3.1. 127, 128 and 129 were used as model compounds for CSA (Fig. 28). The 
tetrabutylammmonium salt of MTPA (132) was utilized as guest.  
 
  
 
Figure 29. Bis(dehydroabietylimidazolium) chloride (127), tetrafluoroborate (128) and 
bis(trifluoromethylsulfonyl)amide (129) and the tetrabutylammmonium salt of MTPA (132). 
 
As mentioned in chapter 3.1 the solvent has effect on Δδ as it can interfere in the 
complex formation between CSA and the guest. Usually the polarity and protic nature of a 
solvent has been considered to cause problems in complex formation. It is interesting that 
the dielectric constant (ε) of a solvent has not been considered as according to Coulomb’s 
law (F = q1q2/εr2) the ε is responsible for coulombic interactions between ions. The effect 
of ε on the resolution was studied with n-Bu4N+MTPA- and CSA 129 (Table 13). Results 
showed that a solvent with a low ε gave the highest Δδ. 
 
Table 13. The effect of solvent to chiral discrimination of the n-Bu4N+MTPA- with 129. (Dielectric 
constants are for non-deuterated solvents) 
 
Solvent ε198 
Δδ  (ppm, (Hz)) 
1H 19F 
CDCl3 4.8 0.0 0.128 (60.2) 
CD2Cl2 9.1 0.0 0.102 (47.9) 
(CD3)2CO 20.6 0.0 0.057 (26.8) 
CD3OD 32.6 0.003 (1.5) 0.0 
CD3CN 37.5 0.0 0.0 
DMSO 46.6 0.0 0.0 
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The effect of concentration of the NMR sample has not been commonly taken into 
account. The effect of concentration on Δδ was noticed during our CSA research and its 
effect was investigated. The effect of sample concentration had a distinct effect when the 
enantiomeric separation of n-Bu4N+MTPA- was measured in the presence of 129 using a 
host guest ratio 1:1 in the 19F NMR measurement (Fig. 29). 
  
 
Figure 30. A The effect of sample concentration  to the change of Δδ. B The change of chemical 
shifts of R (+) and S (Δ) enantiomers. 
 
Even though lower temperatures are known to have a positive effect on Δδ they are 
rarely exploited, and NMR measurements are usually performed at ambient temperature 
(generally +20 to +30 °C). The spectra of n-Bu4N+MTPA- were measured in the presence 
of CSA 129, and Δδ was seen to increase at lower temperatures and to decrease at higher 
temperatures (Fig. 30, B). Even though a decrease of temperature is clearly beneficial it 
has its drawback as peak broadening is increased at lower temperatures (Fig 30, A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. The effect of temperature. Dynamic measurements from -15 to +45 °C: A 19F-NMR 
spectra of n-Bu4N+MTPA- in the presence of 129 and B the Δδ as a function of temperature. 
(Guest: 0.5 mL, 2.0 mM, 1.0 eq and host: 25 µL, 46.6 mM, 1.0 eq) 
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The effect of counter anion of cationic CSA has been widely explored, but the counter 
cation of an anionic guest has drawn less attention. The effect of cation was examined 
with MTPA and its potassium (K+), tetramethylammonium (Me4N+), and 
tetrabutylammonium (n-Bu4N+) salts (Table 14). The highest Δδ was obtained with 
organic cations Me4N+ and n-Bu4N+. However, when Me4N+ was used as the counter 
cation the salt formed between the anion of host (Cl-, BF4- and NTf2-) and Me4N+ did not 
dissolve well in CDCl3 and it precipitated. The precipitate was filtered and in the case of 
CSA 127 Δδ was notably increased. To avoid filtration, water (preferably heavy water 
D2O) may be used to extract the formed counter ion salt (e.g. Me4N+Cl-, Me4N+BF4-, 
Me4N+NTf2-). Even though the use of D2O gave a slightly higher Δδ than filtration, its use 
should be considered if there is concern of possible interference in hydrogen bonding. 
Although the use of Me4N+ as counter cation is more time consuming compared to n-
Bu4N+ the major benefit is that the number of peaks in NMR spectra are reduced (-CH3 vs. 
-(CH2)3CH3). This decreases the possibility of peak overlapping between CSA and the 
chiral guest. 
 
Table 14. The effect of counter cation of the chiral guest. 
 
Guest 
Δδ  with 127 (ppm, (Hz)) Δδ  with 128 (ppm, (Hz)) Δδ  with 129 (ppm, (Hz)) 
1H 19F 1H 19F 1H 19F 
MTPA 0.0056 (2.8) 0.0 0.0071 (3.5) 0.0 0.002 (1.0) 0.0 
       
K+MTPA-  
+ 1.0 eq of 18-crown-6 
0.0 0.042 (19.7) 0.0 0.051 (24.2) 0.0 0.090 (42.5) 
       
n-Bu4N+MTPA- 0.0 0.054 (25.3) 0.0049 (2.5) 0.069 (32.3) 0.0029 (1.5) 0.110 (49.8) 
       
Me4N+MTPA- 0.0079 (3.9) 0.061 (28.5) 0.0071 (3.6) 0.071 (33.4) 0.0034 (1.7) 0.100 (47.9) 
       
Me4N+MTPA- 
filtereda 
0.0091 (4.5) 0.082 (38.4) 0.0086 (4.3) 0.082 (38.4) 0.0024 (1.2) 0.110 (50.6) 
       
Me4N+MTPA- 
+ H2O 
0.0060 (2.8) 0.080 (37.8) 0.0 0.091 (42.9) 0.0 0.115 (54.1) 
a The ammonium salt formed (Me4N+Cl-/BF4-/NTf2-) is poorly soluble in CDCl3 (especially in the case Me4N+Cl-). 
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6 Conclusion 
As the chiral resolution of carboxylic acids is commonly studied with amine based 
CSAs three different (+)-dehydroabietylamine based CSA series were synthesised: 1) 
ammonium, 2) secondary amine and 3) imidazolium, containing both non-ionic and ionic 
CSA. (+)-Dehydroabietylamine was chosen for the source of chirality as it has several 
beneficial structural features and it is known to be able to resolve carboxylic acids. 
 
The synthetic CSAs ability to resolve carboxylic acids in NMR were studied with 
Mosher’s acid (MTPA) and its tetrabutylammonium salt (n-Bu4N+MTPA-). Results 
indicated that the non-ionic CSA resolved better the non-ionic MTPA and the ionic CSAs 
resolved better the ionic n-Bu4N+MTPA-. Resolution efficiency was concluded to 
originate from the formation of a diastereomeric salt. As no diastereomeric salt can be 
formed between the ionic and non-ionic species, the enantiomeric differentiation of the 
non-ionic substrate MTPA remained low with ionic CSAs. The same was observed in the 
case of the ionic substrate n-Bu4N+MTPA- and non-ionic CSAs.  
 
The best performing CSAs 100 and 101 from the ammonium series, 115 and 121 from 
the secondary amine series and 129 from the imidazolium series were subjected to further 
study. The stoichiometry of the formed CSA-substrate complexes, these efficiency in 
enantiomeric excess (ee) studies and the ability to discriminate various α-substituted 
carboxylic acids were studied. Ionic CSAs were tested with ionic substrates and non-ionic 
CSAs with non-ionic substrates. The CSAs 100, 101, 121 and 129 formed complex as in 
1:1 CSA:substrate ratio. However, CSA 115 formed a complex in 0.5:1 CSA:substrate 
ratio. This is advantageous, as usually 1.0 eq of CSA is needed to obtain a maximum 
resolution.  The ee measurements with the CSAs were performed with excellent reliability. 
The chiral resolution of aromatic and non-aromatic α-substituted carboxylic acids 
indicated that carboxylic acids containing an electronegative α-substituent were efficiently 
resolved. Also the ability to use specialised NMR techniques as an aid to enhance 
multiplet resolution was shown to be possible using a modified RES-TOCSY experiment. 
 
The study of the effect of conditions of measurement and sample preparation when 
using cationic CSAs indicated that to enhance the enantiomeric discrimination a solvent 
with low polarity, low measurement temperatures and low sample concentration could be 
beneficial. To enhance the ionic interaction with the CSA cation and the substrate anion, 
the counter anion of CSA should be charge delocalised. Also the effect of the counter 
cation of anionic substrates was studied. The use of organic counter cations for anionic 
substrate was shown to be beneficial causing larger enantiomeric differentiation. Their use 
also reduced the need of additives such as a crown ether and enabled the use of solvents of 
low polarity.  
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